Laura Pucci Selected Research

Lisosan G

1/2021	The Potential of Lisosan G as a Possible Treatment for Glaucoma.
12/2018	Lisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Pucci Research Topics

Disease

11	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 02/2004
8	Inflammation (Inflammations) 09/2022 - 12/2004
7	Hypertension (High Blood Pressure) 06/2009 - 01/2003
6	Insulin Resistance 01/2014 - 02/2004
6	Albuminuria 09/2009 - 12/2004
4	Neoplasms (Cancer) 01/2021 - 06/2007
4	Obesity 01/2017 - 12/2004
4	Essential Hypertension 01/2014 - 12/2004
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 11/2017
2	Hemolysis 04/2018 - 03/2015
2	Atherosclerosis 01/2017 - 02/2004
2	Glucose Intolerance 07/2011 - 09/2009
1	Non-alcoholic Fatty Liver Disease 09/2022
1	Hypercholesterolemia 09/2022
1	Adenocarcinoma 01/2021
1	Glaucoma 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2018
1	Acute Kidney Injury (Acute Renal Failure) 06/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2012
1	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2011
1	Heart Diseases (Heart Disease) 07/2007
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2007
1	Vascular Diseases (Vascular Disease) 12/2006
1	Renal Insufficiency (Renal Failure) 05/2006
1	Cysts 02/2006
1	Hyperinsulinism (Hyperinsulinemia) 02/2005
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2004
1	Hyperglycemia 12/2004
1	Abdominal Obesity 02/2004
1	Diabetes Mellitus 01/2003
1	Diabetes Complications 01/2003

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 07/2011 - 02/2004
9	LipidsIBA 03/2022 - 02/2004
8	AntioxidantsIBA 09/2022 - 01/2014
5	AlbuminsIBA 12/2012 - 02/2004
4	HDL CholesterolIBA 01/2018 - 12/2004
4	CytokinesIBA 03/2017 - 06/2009
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014 - 02/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 02/2004
4	Adenosine Triphosphate (ATP)IBA 01/2014 - 02/2004
4	Insulin (Novolin)FDA Link 12/2006 - 02/2004
4	Triglycerides (Triacylglycerol)IBA 08/2005 - 02/2004
3	Biological ProductsIBA 01/2021 - 06/2009
3	CholesterolIBA 06/2015 - 02/2005
3	HDL LipoproteinsIBA 01/2014 - 12/2004
2	Proteins (Proteins, Gene)FDA Link 03/2022 - 06/2009
2	ResveratrolIBA 01/2021 - 03/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2014
2	Liposomes (Liposome)IBA 01/2021 - 03/2018
2	Lisosan GIBA 01/2021 - 12/2018
2	oxidized low density lipoproteinIBA 01/2016 - 06/2015
2	Fumigant 93 (D-D)IBA 06/2009 - 12/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2007 - 05/2006
2	EnzymesIBA 06/2007 - 12/2006
2	Pharmaceutical PreparationsIBA 06/2007 - 02/2005
2	Cystatin CIBA 03/2007 - 02/2006
1	Biomarkers (Surrogate Marker)IBA 09/2022
1	FructoseIBA 03/2022
1	AdiponectinIBA 03/2022
1	LeptinIBA 03/2022
1	Gemcitabine FDA Link 01/2021
1	protopineIBA 01/2021
1	methylmethacrylate-methacrylic acid copolymerIBA 01/2021
1	artemisinin (artemisinine)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Retinaldehyde (Retinal)IBA 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018
1	SulfitesIBA 04/2018
1	PolyphenolsIBA 03/2018
1	Protein Hydrolysates FDA Link 11/2017
1	Peptides (Polypeptides)IBA 11/2017
1	GlucansIBA 03/2017
1	Transcription Factors (Transcription Factor)IBA 03/2017
1	LipopolysaccharidesIBA 01/2017
1	Fenoldopam (Corlopam)FDA LinkGeneric 06/2015
1	Lipid PeroxidesIBA 06/2015
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2014
1	EsterasesIBA 01/2014
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2014
1	CD40 Ligand (CD40L)IBA 09/2009
1	Lipoproteins (Lipoprotein)IBA 09/2009
1	AcidsIBA 06/2009
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2009
1	prolylarginineIBA 06/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2009
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2007
1	CytochromesIBA 06/2007
1	AngiotensinsIBA 12/2006
1	SaltsIBA 05/2006
1	adducinIBA 05/2006
1	CreatinineIBA 02/2006
1	Doxazosin (Cardura)FDA LinkGeneric 02/2005
1	C-Reactive ProteinIBA 12/2004
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2003
1	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 01/2003

Therapy/Procedure

2	Liver Transplantation 06/2015 - 02/2006